Colour Online: See the article online to view Figs. 1, 2 and 4 in colour.
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression
Article first published online: 13 SEP 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PROTEOMICS - Clinical Applications
Special Issue: Glycan Biomarker Discovery
Volume 7, Issue 9-10, pages 677–689, October 2013
How to Cite
Nyalwidhe, J. O., Betesh, L. R., Powers, T. W., Jones, E. E., White, K. Y., Burch, T. C., Brooks, J., Watson, M. T., Lance, R. S., Troyer, D. A., Semmes, O. J., Mehta, A. and Drake, R. R. (2013), Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Prot. Clin. Appl., 7: 677–689. doi: 10.1002/prca.201200134
- Issue published online: 9 OCT 2013
- Article first published online: 13 SEP 2013
- Accepted manuscript online: 17 JUN 2013 02:15PM EST
- Manuscript Accepted: 30 MAR 2013
- Manuscript Revised: 28 FEB 2013
- Manuscript Received: 18 DEC 2012
- National Institutes of Health/National Cancer Institute. Grant Numbers: R21CA137704, R01CA135087
- state of South Carolina SmartState Endowed Research program. Grant Number: P30 CA138313
- National Cancer Institute (NCI). Grant Numbers: R01 CA120206, U01 CA168856
- Commonwealth of Pennsylvania
- Expressed prostatic secretion;
- N-linked glycosylation;
- Prostate cancer;
- Urine exosome
Using prostatic fluids rich in glycoproteins like prostate-specific antigen and prostatic acid phosphatase (PAP), the goal of this study was to identify the structural types and relative abundance of glycans associated with prostate cancer status for subsequent use in emerging MS-based glycopeptide analysis platforms.
A series of pooled samples of expressed prostatic secretions (EPS) and exosomes reflecting different stages of prostate cancer disease were used for N-linked glycan profiling by three complementary methods, MALDI-TOF profiling, normal-phase HPLC separation, and triple quadropole MS analysis of PAP glycopeptides.
Glycan profiling of N-linked glycans from different EPS fluids indicated a global decrease in larger branched tri- and tetra-antennary glycans. Differential exoglycosidase treatments indicated a substantial increase in bisecting N-acetylglucosamines correlated with disease severity. A triple quadrupole MS analysis of the N-linked glycopeptides sites from PAP in aggressive prostate cancer pools was done to cross-reference with the glycan profiling data.
Conclusion and clinical relevance
Changes in glycosylation as detected in EPS fluids reflect the clinical status of prostate cancer. Defining these molecular signatures at the glycopeptide level in individual samples could improve current approaches of diagnosis and prognosis.